Hall H, Ogren S O
Life Sci. 1984 Feb 6;34(6):597-605. doi: 10.1016/0024-3205(84)90494-6.
The histamine-H1 receptor blocking properties of a number of structurally different antidepressant drugs have been evaluated using a 3H-mepyramine binding assay and a guinea-pig ileum preparation. The tricyclic antidepressants all inhibited the histamine-H1 receptor. Some newer antidepressant drugs, such as zimelidine and nomifensine were devoid of activity while others, such as iprindole and mianserin were very potent. It is concluded that antagonistic effects on the histamine-H1 receptor is not associated with the therapeutic efficacy in depression, but may contribute to the sedative effects of the antidepressant drugs.
已采用³H-美吡拉敏结合试验和豚鼠回肠制备法,对多种结构不同的抗抑郁药物的组胺H1受体阻断特性进行了评估。三环类抗抑郁药均能抑制组胺H1受体。一些较新的抗抑郁药物,如齐美利定和诺米芬辛没有活性,而其他药物,如茚满二胺和米安色林则活性很强。得出的结论是,对组胺H1受体的拮抗作用与抑郁症的治疗效果无关,但可能有助于抗抑郁药物的镇静作用。